Denis Braun

1.4k total citations
20 papers, 307 citations indexed

About

Denis Braun is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Denis Braun has authored 20 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Denis Braun's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (12 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Denis Braun is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (12 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Denis Braun collaborates with scholars based in France and United States. Denis Braun's co-authors include Élisabeth Quoix, Jean-Luc Breton, B Lebeau, D. Debieuvre, Jean Trédaniel, Jean Louis Pujol, F. Vaylet, B. Milleron, A Ducoloné and P. Clouet and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and CHEST Journal.

In The Last Decade

Denis Braun

20 papers receiving 291 citations

Peers

Denis Braun
Eric M. Robinson United States
Simonetta Chiara Stani Italy
J. K. Choksi United States
Julien Langrand-Escure France
Beata Jagielska Poland
Shireen Parsai United States
Haocan Song United States
Vijai Simha India
Sheila Hodgson United States
Céline Ségura‐Ferlay France
Eric M. Robinson United States
Denis Braun
Citations per year, relative to Denis Braun Denis Braun (= 1×) peers Eric M. Robinson

Countries citing papers authored by Denis Braun

Since Specialization
Citations

This map shows the geographic impact of Denis Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Braun more than expected).

Fields of papers citing papers by Denis Braun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Braun. The network helps show where Denis Braun may publish in the future.

Co-authorship network of co-authors of Denis Braun

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Braun. A scholar is included among the top collaborators of Denis Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Braun. Denis Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westeel, Virginie, Fabrice Barlési, J.J. Lafitte, et al.. (2017). Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC). Annals of Oncology. 28. v452–v452. 25 indexed citations
2.
3.
Zalcman, Gérard, Guénaëlle Levallet, Pierre Fouret, et al.. (2013). A DNA-repair prognostic signature for early-stage NSCLC patients, in IFCT-0002 trial of neoadjuvant chemotherapy.. Journal of Clinical Oncology. 31(15_suppl). 7515–7515. 2 indexed citations
4.
Fraipont, Florence de, Guénaëlle Levallet, Christian Créveuil, et al.. (2012). An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial. Clinical Cancer Research. 18(10). 2976–2986. 46 indexed citations
5.
Westeel, Virginie, Fabrice Barlési, Philippe Girard, et al.. (2012). Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302).. Journal of Clinical Oncology. 30(15_suppl). TPS7111–TPS7111. 1 indexed citations
6.
Quoix, Élisabeth, I. Monnet, Philippe Scheid, et al.. (2010). IFCT 02-02 : la prise en charge du cancer bronchique chez les patients âgés de 70 ans et plus en France. Revue des Maladies Respiratoires. 27(5). 421–430. 22 indexed citations
7.
Westeel, V., B. Milleron, Élisabeth Quoix, et al.. (2010). Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer.. Journal of Clinical Oncology. 28(15_suppl). 7003–7003. 8 indexed citations
8.
Westeel, Virginie, B. Milleron, Élisabeth Quoix, et al.. (2009). Results of the IFCT 0002 phase III study comparing a preoperative and a perioperative chemotherapy (CT) with two different CT regimens in resectable non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 27(15_suppl). 7530–7530. 8 indexed citations
9.
Spaëth, D., et al.. (2008). Efficacy and safety of cooling helmets (CH) for the prevention of chemotherapy-induced alopecia (CIA): A prospective study of 911 patients (pts). Journal of Clinical Oncology. 26(15_suppl). 9564–9564. 10 indexed citations
10.
11.
Milleron, B., Élisabeth Quoix, V. Westeel, et al.. (2007). IFCT0002 phase III study comparing a preoperative (PRE) and a perioperative (PERI) chemotherapy with two different CT regimens in resectable non-small cell lung cancer (NSCLC): Early results. Journal of Clinical Oncology. 25(18_suppl). 7519–7519. 2 indexed citations
12.
Milleron, B., Virginie Westeel, Élisabeth Quoix, et al.. (2005). Complete Response Following Preoperative Chemotherapy for Resectable Non-Small Cell Lung Cancer. CHEST Journal. 128(3). 1442–1447. 13 indexed citations
13.
Gervais, R., A Ducoloné, Jean-Luc Breton, et al.. (2004). Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Annals of Oncology. 16(1). 90–96. 104 indexed citations
14.
Braun, Denis, et al.. (2004). Rupture of multiple tendons after levofloxacin therapy. Joint Bone Spine. 71(6). 586–587. 11 indexed citations
15.
Piquet, J., F Blanchon, M Grivaux, et al.. (2004). Le cancer bronchique primitif du sujet âgé en France. Revue des Maladies Respiratoires. 21(5). 70–78. 9 indexed citations
16.
Blanchon, F, M Grivaux, T. Collon, et al.. (2004). [Primary lung cancer in elderly subjects in France].. PubMed. 21(5 Pt 3). 8S70–8. 12 indexed citations
17.
18.
Blanchon, F, M Grivaux, T. Collon, et al.. (2003). [Primary bronchial carcinoma in elderly subjects in France].. PubMed. 20(5 Pt 1). 691–9. 12 indexed citations
19.
Depierre, A, B. Milleron, D Moro, et al.. (1995). 1053 Phase III study of neo-adjuvant chemotherapy in resectable non-small cell lung cancer (NSCLC). European Journal of Cancer. 31. S220–S220. 1 indexed citations
20.
Borchard, F, et al.. (1982). [Morphologic findings in 3 children with Zellweger's syndrome with special attention to cytochemical studies].. PubMed. 66. 422–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric M. Robinson Breakdown of academic impact, for papers by Simonetta Chiara Stani Breakdown of academic impact, for papers by J. K. Choksi Breakdown of academic impact, for papers by Julien Langrand-Escure Breakdown of academic impact, for papers by Beata Jagielska Breakdown of academic impact, for papers by Shireen Parsai Breakdown of academic impact, for papers by Haocan Song Breakdown of academic impact, for papers by Vijai Simha Breakdown of academic impact, for papers by Sheila Hodgson Breakdown of academic impact, for papers by Céline Ségura‐Ferlay
Rankless by CCL
2026